JPS525764A - Production of pyrrolidone - Google Patents
Production of pyrrolidoneInfo
- Publication number
- JPS525764A JPS525764A JP51075954A JP7595476A JPS525764A JP S525764 A JPS525764 A JP S525764A JP 51075954 A JP51075954 A JP 51075954A JP 7595476 A JP7595476 A JP 7595476A JP S525764 A JPS525764 A JP S525764A
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidone
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752528664 DE2528664A1 (de) | 1975-06-27 | 1975-06-27 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS525764A true JPS525764A (en) | 1977-01-17 |
Family
ID=5950059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51075954A Pending JPS525764A (en) | 1975-06-27 | 1976-06-26 | Production of pyrrolidone |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS525764A (cg-RX-API-DMAC7.html) |
| AT (1) | AT365575B (cg-RX-API-DMAC7.html) |
| BE (1) | BE843505A (cg-RX-API-DMAC7.html) |
| CH (1) | CH623809A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2528664A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK287476A (cg-RX-API-DMAC7.html) |
| ES (1) | ES449095A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2316943A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1553595A (cg-RX-API-DMAC7.html) |
| IL (1) | IL49916A0 (cg-RX-API-DMAC7.html) |
| LU (1) | LU75235A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7606773A (cg-RX-API-DMAC7.html) |
| SE (1) | SE7607331L (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA763802B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (ja) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 眼圧降下剤としての８−アザプロスタグランジン類似体 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE423813B (sv) * | 1976-08-06 | 1982-06-07 | Pfizer | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper |
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| OA12117A (en) | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| NZ525164A (en) | 2000-11-27 | 2005-04-29 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
| BR0211201A (pt) | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
| ES2289140T3 (es) | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| BR0308738A (cg-RX-API-DMAC7.html) * | 2002-03-18 | 2005-01-11 | ||
| CN1735597A (zh) | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2－哌啶酮衍生物 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US9440919B2 (en) | 2012-07-19 | 2016-09-13 | Cayman Chemical Company, Inc. | Difluorolactam compositions for EP4-mediated osteo related diseases and conditions |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| JP6317807B2 (ja) | 2013-03-15 | 2018-04-25 | ケイマン ケミカル カンパニー， インコーポレーテッド | Ｅｐ４媒介性の疾病及び病態の治療に使用するためのｅｐ４受容体選択性アゴニストとしてのラクタム化合物 |
| WO2014144500A2 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| AU2014290512A1 (en) | 2013-07-19 | 2015-11-12 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/de not_active Withdrawn
-
1976
- 1976-06-22 NL NL7606773A patent/NL7606773A/xx not_active Application Discontinuation
- 1976-06-22 ES ES449095A patent/ES449095A1/es not_active Expired
- 1976-06-24 SE SE7607331A patent/SE7607331L/xx unknown
- 1976-06-24 CH CH809976A patent/CH623809A5/de not_active IP Right Cessation
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-25 DK DK287476A patent/DK287476A/da unknown
- 1976-06-25 AT AT0467976A patent/AT365575B/de active
- 1976-06-25 IL IL49916A patent/IL49916A0/xx unknown
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-25 ZA ZA763802A patent/ZA763802B/xx unknown
- 1976-06-26 JP JP51075954A patent/JPS525764A/ja active Pending
- 1976-06-28 BE BE168390A patent/BE843505A/xx not_active IP Right Cessation
- 1976-06-28 FR FR7619563A patent/FR2316943A1/fr active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (ja) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 眼圧降下剤としての８−アザプロスタグランジン類似体 |
Also Published As
| Publication number | Publication date |
|---|---|
| ATA467976A (de) | 1981-06-15 |
| GB1553595A (en) | 1979-09-26 |
| FR2316943A1 (fr) | 1977-02-04 |
| DE2528664A1 (de) | 1977-01-13 |
| ZA763802B (en) | 1977-05-25 |
| NL7606773A (nl) | 1976-12-29 |
| ES449095A1 (es) | 1977-12-16 |
| FR2316943B1 (cg-RX-API-DMAC7.html) | 1978-11-03 |
| AT365575B (de) | 1982-01-25 |
| BE843505A (fr) | 1976-12-28 |
| DK287476A (da) | 1976-12-28 |
| SE7607331L (sv) | 1976-12-28 |
| CH623809A5 (en) | 1981-06-30 |
| LU75235A1 (cg-RX-API-DMAC7.html) | 1977-03-16 |
| IL49916A0 (en) | 1976-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS51118763A (en) | Production of alkylenecarbonate | |
| JPS5236683A (en) | Production of riphamycin | |
| JPS525764A (en) | Production of pyrrolidone | |
| JPS5212162A (en) | Production of phenylindoline | |
| JPS51141897A (en) | Production of riphamycin | |
| JPS5251392A (en) | Production of triazolopyridazinones | |
| JPS51131873A (en) | Production of 44loneralkyll 55cyanoooxazole | |
| JPS527958A (en) | Production of 22 pyrrolidone | |
| JPS525762A (en) | Production of betaa acylpyrol | |
| JPS5248698A (en) | Production of riphamycin | |
| JPS5273865A (en) | Production of novel pyrrolidone | |
| JPS51115473A (en) | Production of lower alkylimidazolecarboxylate | |
| JPS5289667A (en) | Production of nnsubstituted spirolaltam | |
| JPS5219695A (en) | Production of tetrahydrothiopyranopyrazols | |
| JPS51115465A (en) | Production of 55phenyll 22framidoxime | |
| JPS5227758A (en) | Production of 22methyll 11naphthol | |
| JPS5248689A (en) | Production of pyrazolopyridineketones | |
| JPS51130543A (en) | Production of instant onigiri | |
| JPS5273858A (en) | Production of phospholenee 11calcogenite | |
| JPS5248662A (en) | Production of 44hydroxymethyll 22pyrorysines | |
| JPS5246100A (en) | Production of pyrazolopyridopirimidine | |
| JPS5236690A (en) | Production of 33methoxymethlcephalosporin | |
| JPS5212991A (en) | Production of bioprotein | |
| JPS51128997A (en) | Production of pyrazolopyridineketones | |
| JPS5265286A (en) | Production of epsilonn caprolactam |